Model.IsUpcomingAward = False Model.IsLoggedOut=False Model.PassedInYear=2023 Model.LastYear=2024 Model.ShowLoggedOut=True
 
 
 
2023 Best In Klas
 

Drug Diversion Monitoring

 
 
 
 
A+ = >95.0
A = 91.0-94.9
A- = 88.0-90.9
B+ = 85.0-87.9
B = 81.0-84.9
B- = 78.0-80.9
C+ = 75.0-77.9
C = 71.0-74.9
C- = 68.0-70.9
D+ = 65.0-67.9
D = 61.0-64.9
D- = 58.0-60.9
F = <58.0
 
 
Ranked Solutions
Category average: 80.1
Software average: 80.3
Grading Scale

Company/solution
Overall performance score
(100-point scale)
Total
evaluations
Trend
(2022-2023)
Culture
Loyalty
Operations
Product
Relationship
Value
                   
Protenus
Diversion Analytics  
KLAS comments icon
87.7
n=18
N/A
A-
A-
B
B+
A
A-
         
 
 
 
 
 
Bluesight
ControlCheck (formerly Bluesight for Controlled Substances)  
KLAS comments icon
86.6
n=33
-5%
B
A-
B
B
A-
B+
         
 
 
 
 
 
BD
HealthSight Diversion Management  
KLAS comments icon
79.5
n=24
N/A
C+
B
C+
C+
B
B-
 
50.0
100.0
 
Company/solution
Trend
(2022-2023)
KLAS Culture Icon
Culture
KLAS Loyalty Icon
Loyalty
KLAS Operations Icon
Operations
KLAS Product Icon
Product
KLAS Relationship Icon
Relationship
KLAS Value Icon
Value
                 
Protenus
Diversion Analytics
 
87.7
n=18
KLAS comments icon  COMMENTS
    N/A
A-
A-
B
B+
A
A-
Bluesight
ControlCheck (formerly Bluesight for Controlled Substances)
 
86.6
n=33
KLAS comments icon  COMMENTS
    -5%
B
A-
B
B
A-
B+
BD
HealthSight Diversion Management
 
79.5
n=24
KLAS comments icon  COMMENTS
    N/A
C+
B
C+
C+
B
B-
Company/solution
 
Censinet assessment N/A
 
culture
A-
loyalty
A-
operations
B
product
B+
relationship
A
value
A-
 
KLAS comments icon  COMMENTS
 
Censinet assessment N/A
 
culture
B
loyalty
A-
operations
B
product
B
relationship
A-
value
B+
 
KLAS comments icon  COMMENTS
 
Censinet assessment N/A
 
culture
C+
loyalty
B
operations
C+
product
C+
relationship
B
value
B-
 
KLAS comments icon  COMMENTS
 
 
 
 
SolutionsNotRanked_Symbol  
Solutions Not Ranked
 


L      
Company/solution
Overall performance score
(100-point scale)
Total
evaluations
Culture
Loyalty
Operations
Product
Relationship
Value
                 
Bluesight
Medacist RxAuditor Investigate/RxAuditor *
L
63.2
n=11
D-
F
C-
D
B
C+
       
 
 
 
 
 
Imprivata
FairWarning Drug Diversion Intelligence *
L
64.6
n=15
F
D
C-
D
C
C-
       
 
 
 
 
 
Wolters Kluwer
Invistics Flowlytics *
L
80.2
n=10
C
B
C+
B-
B
B
 

L      
Company/solution
Overall performance score (100-point scale)
Total
evaluations
     
Bluesight
Medacist RxAuditor Investigate/RxAuditor *
L
culture
D-
loyalty
F
operations
C-
product
D
relationship
B
value
C+
63.2
n=11
     
Imprivata
FairWarning Drug Diversion Intelligence *
L
culture
F
loyalty
D
operations
C-
product
D
relationship
C
value
C-
64.6
n=15
     
Wolters Kluwer
Invistics Flowlytics *
L
culture
C
loyalty
B
operations
C+
product
B-
relationship
B
value
B
80.2
n=10
 

L      

Company/solution
Bluesight
Medacist RxAuditor Investigate/RxAuditor * L
63.2
n=11
culture
D-
loyalty
F
operations
C-
product
D
relationship
B
value
C+
 

Imprivata
FairWarning Drug Diversion Intelligence * L
64.6
n=15
culture
F
loyalty
D
operations
C-
product
D
relationship
C
value
C-
 

Wolters Kluwer
Invistics Flowlytics * L
80.2
n=10
culture
C
loyalty
B
operations
C+
product
B-
relationship
B
value
B
 
 
 
 
OtherNotablePerformances_Symbol  
Other notable performances in Drug Diversion Monitoring Other notable performances
 


Solutions for which at least 95% of respondents answered yes.
Avoids charging for every little thing?
Protenus
Protenus Diversion Analytics
n=15  100%
Part of long-term plans?
BD
BD HealthSight Diversion Management
n=21  96%
Avoids charging for every little thing?
Protenus
Protenus Diversion Analytics
n=15  100%
 
Part of Long Term Plans?
BD
BD HealthSight Diversion Management
n=21  96%
 
 
 
 
 
 
 

Past Drug Diversion Monitoring Awards